Breast Cancer
Breast Cancer
FASTEX Study
A pilot non-randomised controlled trial to examine the efficacy and the effects on the immune system of a fasting mimicking diet and a supervised exercise program in patients with breast cancer undergoing neoadjuvant treatment.
Inclusion criteria:
- Women aged 18 years and older, diagnosed with breast cancer and scheduled for neoadjuvant chemotherapy.
Exclusion criteria:
- Having a body mass index (BMI) lower than 19 kg/m2;
- Having impaired gastrointestinal function that may alter the digestion and absorption of nutrients (e.g., uncontrolled nausea, vomiting, diarrhoea);
- Taking medication that can cause hypoglycemia (e.g., insulin for diabetes);
- Having malnutrition (unintentional weight loss of >5% in the last 6 months);
- Having an uncontrolled medical condition (other than cancer);
- Inability to read or understand English;
- Being pregnant or breastfeeding;
- Having undertaken 300 min or more of exercise per week in the previous month prior to inclusion in the study;
- Having an acute illness or musculoskeletal, cardiovascular, or neurological disorder that could inhibit exercise participation.
Enrol in this trial program
The Exercise Medicine Research Institute has a number of ongoing research projects which are currently open for patient enrolment. Patients who may be eligible for any of these projects can contact our team for further information on 6304 3444 or at trials@exercisemedicine.org.au
